review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Solikhah Solikhah | |
Sitti Nurdjannah | |||
P2860 | cites work | Projecting individualized probabilities of developing breast cancer for white females who are being examined annually | Q69396132 |
Followup after 11 years--update of mortality results in the Stockholm mammographic screening trial | Q73916564 | ||
14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening | Q77890330 | ||
Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus | Q80262898 | ||
[Application of the Gail method of calculating risk in the population of Valencia] | Q81264815 | ||
Prognosis and prognostic research: validating a prognostic model | Q83939735 | ||
Risk of developing breast cancer by utilizing Gail model | Q84145864 | ||
Quantifying the added value of new biomarkers: how and how not | Q92058066 | ||
Mammography screening in less developed countries | Q26778678 | ||
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study | Q28281843 | ||
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond | Q29614697 | ||
Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women | Q30501421 | ||
Assessment and comparison of prognostic classification schemes for survival data. | Q30581228 | ||
Validation of Rosner-Colditz breast cancer incidence model using an independent data set, the California Teachers Study | Q30683824 | ||
Review and evaluation of performance measures for survival prediction models in external validation settings | Q33576899 | ||
Breast cancer screening in developing countries | Q33592686 | ||
Managing the changing burden of cancer in Asia | Q33643009 | ||
Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance | Q33739374 | ||
Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction model | Q33763777 | ||
What do we mean by validating a prognostic model? | Q33849998 | ||
Validation of risk assessment models for predicting the incidence of breast cancer in korean women | Q34340596 | ||
Assessing risk of breast cancer in an ethnically South-East Asia population (results of a multiple ethnic groups study). | Q34481239 | ||
Decision curve analysis: a novel method for evaluating prediction models | Q34581068 | ||
The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms | Q35030287 | ||
Korean risk assessment model for breast cancer risk prediction | Q35034785 | ||
Lifestyle changes for prevention of breast cancer | Q35072262 | ||
Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial | Q35704073 | ||
Lifetime and 5 years risk of breast cancer and attributable risk factor according to Gail model in Iranian women | Q35895900 | ||
Awareness, Attitude, and Practice of Breast Cancer Screening Women, and the Associated Socio-Demographic Characteristics, in Northern Iran | Q36163301 | ||
Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort | Q36336239 | ||
Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women | Q36393167 | ||
Impact of a primary care based intervention on breast cancer knowledge, risk perception and concern: A randomized, controlled trial | Q36422319 | ||
Recalibration of the Gail model for predicting invasive breast cancer risk in Spanish women: a population-based cohort study | Q36649796 | ||
Primary extraosseous Ewing sarcoma of the lung in children | Q36791086 | ||
Breast cancer risk assessments comparing Gail and CARE models in African-American women | Q37139866 | ||
Assessment of the clinical utility of the Gail model in estimating the risk of breast cancer in women from the Indian population | Q37232252 | ||
Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide | Q38193133 | ||
Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women | Q39076835 | ||
Lifestyle modifications for patients with breast cancer to improve prognosis and optimize overall health | Q39155233 | ||
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. | Q39608822 | ||
Clinico-epidemiological profile of breast cancer patients and the retrospective application of Gail model 2: An Indian perspective | Q39768170 | ||
Incidence and Mortality and Epidemiology of Breast Cancer in the World | Q39777975 | ||
Risk of breast cancer, health beliefs and screening behaviour among Turkish academic women and housewives. | Q39985217 | ||
Projecting individualized absolute invasive breast cancer risk in African American women | Q40149673 | ||
Breast cancer screening with mammography: overview of Swedish randomised trials | Q40709256 | ||
CONSORT: when and how to use it. | Q40758674 | ||
Breast cancer risk assessment using the Gail model: a Turkish study | Q41498208 | ||
Gail model risk assessment and risk perceptions | Q44902714 | ||
Breast cancer risk and early diagnosis applications in Turkish women aged 50 and over | Q45129384 | ||
Assessing breast cancer risk models in Marin County, a population with high rates of delayed childbirth. | Q45956105 | ||
Gail model risk factors: impact of adding an extended family history for breast cancer. | Q46015936 | ||
Breast cancer risk assessment in indigent women at a public hospital | Q46902228 | ||
Breast Cancer Risk Assessment Using the Gail Model and It’s Predictors in Saudi Women | Q47207420 | ||
Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement | Q47555051 | ||
Assessing Breast Cancer Risk among Iranian Women Using the Gail Model | Q47683555 | ||
Assessing Breast Cancer Risk Estimates Based on the Gail Model and Its Predictors in Qatari Women | Q47733514 | ||
Evaluation of periodic breast cancer screening with mammography: methodology and early observations. 1966. | Q49100908 | ||
Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial | Q50596721 | ||
A comparison between different prediction models for invasive breast cancer occurrence in the French E3N cohort | Q50597400 | ||
Validation studies for models projecting the risk of invasive and total breast cancer incidence | Q50651945 | ||
Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years | Q50665087 | ||
Breast cancer in South Asia: a Bangladeshi perspective. | Q51044303 | ||
Can the Gail model increase the predictive value of a positive mammogram in a European population screening setting? Results from a Spanish cohort. | Q51301769 | ||
Applicability of the Gail model for breast cancer risk assessment in Turkish female population and evaluation of breastfeeding as a risk factor. | Q51614534 | ||
Statistical methods for the assessment of prognostic biomarkers(part II): calibration and re-classification. | Q51720552 | ||
Breast cancer risk assessment in the Czech female population--an adjustment of the original Gail model. | Q51830214 | ||
Breast Cancer Risk Based on the Gail Model and its Predictors in Iranian Women. | Q54483352 | ||
The impact of patient, intervention, comparison, outcome (PICO) as a search strategy tool on literature search quality: a systematic review | Q57057793 | ||
Use of Receiver Operating Characteristic (ROC) Curve Analysis for Tyrer-Cuzick and Gail in Breast Cancer Screening in Jiangxi Province, China | Q58793000 | ||
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | Q60142201 | ||
Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women | Q60942791 | ||
Assessing New Biomarkers and Predictive Models for Use in Clinical Practice | Q61853452 | ||
Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model | Q64074174 | ||
P433 | issue | 4 | |
P304 | page(s) | e03794 | |
P577 | publication date | 2020-04-22 | |
P1433 | published in | Heliyon | Q27727019 |
P1476 | title | Assessment of the risk of developing breast cancer using the Gail model in Asian females: A systematic review | |
P478 | volume | 6 |
Search more.